Patents by Inventor Derek Jo Sakata

Derek Jo Sakata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220273672
    Abstract: The present invention relates to Orally Inhaled and Nasal Drug Product (OINDP) comprising a benzodiazepine, in particular remimazolam.
    Type: Application
    Filed: January 6, 2022
    Publication date: September 1, 2022
    Inventors: Karl-Uwe PETERSEN, Derek Jo SAKATA, Thomas STÕHR, John GRAHAM, Brett COOPER, Tatjana BEVANS, Christopher REILLY
  • Publication number: 20200253983
    Abstract: The present invention relates to Orally Inhaled and Nasal Drug Product (OINDP) comprising a benzodiazepine, in particular remimazolam.
    Type: Application
    Filed: March 24, 2020
    Publication date: August 13, 2020
    Inventors: Karl-Uwe Petersen, Derek Jo Sakata, Thomas Stohr, John Graham, Brett Coopers, Tatjana Bevans, Christopher Reilly
  • Publication number: 20190175613
    Abstract: The present invention relates to Orally Inhaled and Nasal Drug Product (OINDP) comprising a benzodiazepine, in particular remimazolam.
    Type: Application
    Filed: April 18, 2017
    Publication date: June 13, 2019
    Applicant: Paion UK Limited
    Inventors: Karl-Uwe Petersen, Derek Jo Sakata, Thomas Stöhr, John Graham, Brett Cooper, Tatjana Bevans, Christopher Reilly
  • Publication number: 20120055481
    Abstract: An apparatus for reversing inhaled anesthesia, which may be configured to be positioned along a breathing circuit or anesthesia delivery circuit, includes an anesthesia removal component and a blood flow acceleration component. The blood flow acceleration component facilitates an increase in the ventilation of the individual without resulting in a significant decrease in the individual's PaCO2 level and, thus, a decrease in the rate at which blood flows through the individual's brain. A method of reversing the effects of inhaled anesthesia includes increasing the rate of ventilation of an anesthetized individual while causing the individual to inhale gases with at least atmospheric amounts of CO2.
    Type: Application
    Filed: February 22, 2011
    Publication date: March 8, 2012
    Applicant: ANECARE, LLC
    Inventors: Joseph A. Orr, Derek Jo Sakata, Dwayne R. Westenskow
  • Patent number: 7353825
    Abstract: An apparatus for reversing inhaled anesthesia, which is configured to be positioned along a breathing circuit or anesthesia delivery circuit, includes a filter for removing one or more anesthetic agents from gases passing therethrough, as well as a component for elevating CO2 levels in gases that are to be inhaled by an individual. The apparatus is configured to be positioned between a Y-connector of the breathing circuit and the portion of the breathing circuit that interfaces with the individual. The CO2 level-elevating component facilitates an increase in the ventilation of the individual without resulting in a significant decrease in the individual's PaCO2 level and, thus, a decrease in the rate at which blood flows through the individual's brain. A method of reversing the effects of inhaled anesthesia includes increasing the rate of ventilation of an anesthetized individual while causing the individual to inhale gases with elevated amounts of CO2 and while filtering anesthetic agents from such gases.
    Type: Grant
    Filed: October 7, 2003
    Date of Patent: April 8, 2008
    Assignee: Axon Medical, Inc.
    Inventors: Joseph A. Orr, Derek Jo Sakata, Dwayne R. Westenskow
  • Publication number: 20040216743
    Abstract: An apparatus for reversing inhaled anesthesia, which is configured to be positioned along a breathing circuit or anesthesia delivery circuit, includes a filter for removing one or more anesthetic agents from gases passing therethrough, as well as a component for elevating CO2 levels in gases that are to be inhaled by an individual. The apparatus is configured to be positioned between a Y-connector of the breathing circuit and the portion of the breathing circuit that interfaces with the individual. The CO2 level-elevating component facilitates an increase in the ventilation of the individual without resulting in a significant decrease in the individual's PaCO2 level and, thus, a decrease in the rate at which blood flows through the individual's brain. A method of reversing the effects of inhaled anesthesia includes increasing the rate of ventilation of an anesthetized individual while causing the individual to inhale gases with elevated amounts of CO2 and while filtering anesthetic agents from such gases.
    Type: Application
    Filed: October 7, 2003
    Publication date: November 4, 2004
    Inventors: Joseph A. Orr, Derek Jo Sakata, Dwayne R. Westenskow